Host Adriane Berg interviews Dr. Zan Fleming on GENERATION BOLD RADIO
Listen at https://www.generationboldradio.us/
Diabetes digital app technology: benefits, challenges, and recommendations
Co-Authored By Kinexum Founder and Executive Chairman, G. Alexander Fleming, M.D.
-
Translational Research & Strategic Services
Kinexum guides, designs, and manages strategic and operational solutions to the regulatory, manufacturing, nonclinical, clinical development, and business challenges necessary to take scientific discoveries to proof of concept and through the product life cycle.
Kinexum teams supplement the strengths of large and small organizations to reach high-value milestones effectively and efficiently. Kinexum specializes in crafting creative but sound and integrated solutions across scientific disciplines, therapeutic areas, product modalities, and business stages. We respond to emergencies and as well as requests for problem prevention and complex long-range planning.
NEWS AND UPCOMING EVENTS.
DON'T MISS Our Next Webinar!
Register Today! Changes and news at FDA: wow or yeow!?
A special annual roundtable discussion, co-hosted by Kinexum and Hogan Lovells, will focus on the direction of FDA in the new year and beyond.
LISTEN NOW! TEA, DRAGON’S BLOOD, CANNABIS AND GINSENG: HERBAL MEDICINE, DIETARY SUPPLEMENTS OR BOTANICAL DRUGS? by Jinhui Dou, Ph.D. To view Slides Click HERE.
LATEST PUBLISHED ARTICLE! The Need for Precision Medicine to be Applied to Diabetes. Alexander Fleming, MD, David C. Klonoff, MD, FACP, FRCP (Edin), Jose C. Florez, MD, PhD, and Michael German, MD.
Browse our Upcoming Meetings to see where and when you can hear Kinexum Executive Chairman and Founder, Dr. Zan Fleming, speak or if interested, meet with a Kinexum Team Member.
KINEXIUM NEWSLETTER
Featured Articles From Our Desks
Why Kinexum?
Spanning pharmaceuticals, biologics, and devices, we have supported over 250 clients during the past decade to achieve their goals. Kinexum uniquely brings together:
- Exceptional experience — Kinexum professionals have 25 years or more in their specialties.
- Key knowledge — Kinexum professionals reached leadership positions in major regulatory organizations, pharmaceutical companies, and other business and government organizations.
- High recognition and involvement — Kinexum professionals are thought leaders in their fields, frequent conference speakers, and associated with innovative initiatives.
- Large asset of valuable, deployable relationships — Kinexum professionals have built a vast worldwide network of experts and resources across academia, government, and business.
Areas of Expertise
We specialize in chronic metabolic diseases including diabetes, obesity, oncology, immunology, cardiometabolic, neuropathy and their complications.
Kinexum has provided support over the past decade to many of the leading companies developing therapies for diabetes, obesity and metabolism and a growing list of oncology and cardiovascular companies. With high unmet needs and growing healthcare costs, innovative and personalized approaches for the treatment of chronic metabolic diseases are of high value and interest.
Translational Development Services
Today, translational research and development faces what has been called the “valley of death”—the precarious, day to day challenge of managing high costs and risks of early stage development with limited resources. Traversing this stage of health product development requires an integrated strategy for achieving regulatory, preclinical, CMC, and clinical objectives.
Efficient utilization of limited resources is required to create value that will maintain funding momentum. Kinexum professionals are experts in supplementing the technical, operational, and business needs of a small company.
Kinexum provides a personalized approach to understanding and meeting the challenges and obstacles faced by science-driven organizations.
